Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.515 | 0.840 | 19 | 41353016 | missense variant | G/A;C | snv | 0.55; 2.4E-04 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.100 | 0.727 | 22 | 2003 | 2019 | |||||||
|
0.515 | 0.840 | 19 | 41353016 | missense variant | G/A;C | snv | 0.55; 2.4E-04 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.100 | 0.727 | 22 | 2003 | 2019 | |||||||
|
0.515 | 0.840 | 19 | 41353016 | missense variant | G/A;C | snv | 0.55; 2.4E-04 |
|
Nutritional and Metabolic Diseases; Musculoskeletal Diseases | 0.050 | 1.000 | 5 | 2000 | 2013 | |||||||
|
1.000 | 0.080 | 19 | 41342230 | missense variant | G/A | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases | 0.740 | 1.000 | 4 | 2003 | 2014 | ||||||||
|
0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 |
|
Digestive System Diseases; Neoplasms | 0.710 | 1.000 | 4 | 2011 | 2016 | |||||||
|
0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.040 | 0.750 | 4 | 2012 | 2019 | |||||||
|
0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 |
|
Respiratory Tract Diseases | 0.040 | 1.000 | 4 | 2004 | 2017 | |||||||
|
0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 |
|
Digestive System Diseases; Neoplasms | 0.810 | 1.000 | 4 | 2014 | 2018 | |||||||
|
0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.040 | 0.750 | 4 | 2012 | 2019 | |||||||
|
0.752 | 0.360 | 19 | 41341955 | missense variant | G/A | snv | 2.6E-02 | 2.3E-02 |
|
Otorhinolaryngologic Diseases | 0.040 | 1.000 | 4 | 2007 | 2018 | ||||||
|
0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 3 | 2014 | 2016 | |||||||
|
0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 |
|
0.700 | 1.000 | 3 | 2014 | 2016 | ||||||||
|
0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 |
|
0.700 | 1.000 | 3 | 2014 | 2016 | ||||||||
|
0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 |
|
0.700 | 1.000 | 3 | 2014 | 2016 | ||||||||
|
0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 |
|
0.700 | 1.000 | 3 | 2014 | 2016 | ||||||||
|
0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 3 | 2014 | 2016 | |||||||
|
0.547 | 0.760 | 19 | 41354391 | intron variant | A/G | snv | 0.69 |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 3 | 2014 | 2016 | |||||||
|
0.515 | 0.840 | 19 | 41353016 | missense variant | G/A;C | snv | 0.55; 2.4E-04 |
|
Neoplasms; Male Urogenital Diseases | 0.030 | 0.667 | 3 | 2007 | 2014 | |||||||
|
0.515 | 0.840 | 19 | 41353016 | missense variant | G/A;C | snv | 0.55; 2.4E-04 |
|
Neoplasms; Male Urogenital Diseases | 0.030 | 0.667 | 3 | 2007 | 2014 | |||||||
|
0.515 | 0.840 | 19 | 41353016 | missense variant | G/A;C | snv | 0.55; 2.4E-04 |
|
Respiratory Tract Diseases | 0.030 | 1.000 | 3 | 2010 | 2016 | |||||||
|
0.597 | 0.840 | 19 | 41352971 | missense variant | C/G;T | snv | 5.6E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2013 | 2019 | |||||||
|
0.597 | 0.840 | 19 | 41352971 | missense variant | C/G;T | snv | 5.6E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2013 | 2019 | |||||||
|
0.649 | 0.640 | 19 | 41353016 | missense variant | G/A;C | snv |
|
Respiratory Tract Diseases | 0.030 | 0.333 | 3 | 2004 | 2017 | ||||||||
|
0.649 | 0.640 | 19 | 41353016 | missense variant | G/A;C | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2011 | 2019 | ||||||||
|
0.649 | 0.640 | 19 | 41353016 | missense variant | G/A;C | snv |
|
Neoplasms | 0.030 | 1.000 | 3 | 2011 | 2018 |